Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 31 h ago

ALX ONCOLOGY HOLDINGS INC: Coastlands Capital LP discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 19 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Coastlands Capital LP disclosed a stake exceeding 5% in ALX Oncology Holdings Inc. via a Schedule 13G filing with the SEC (accession 0001104659-26-130295). The exact share count and percentage were not specified in the filing headline. The disclosure signals a significant new or expanded position by the institutional investor in the clinical-stage immuno-oncology company. Investors will watch for further detail on the size and intent of the stake, including whether it reflects passive or activist interest.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Coastlands Capital LP, ALX Oncology Holdings Inc